EUVIMEDEUVIMED entdecken
Leserbrief

Dupilumab as a novel therapy for epidermolysis bullosa pruriginosa

Lei Shao, Dao-Qing Zhong, Yu-Mei Liu, Jian-Qin Wang

International Journal of Dermatology · 2023

DOI: 10.1111/ijd.16752 ↗

Kurz gefasst

Leserbrief in der Zeitschrift International Journal of Dermatology, 2023. Verfasst von Lei Shao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Guangzhou Institute of Dermatology, Guangzhou, China. Hauptthemen laut MEDLINE: Epidermolysis Bullosa Dystrophica, Epidermolysis Bullosa. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 5 Literaturangaben. Gefördert von: Science and Technology General guidance project of Guangzhou Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epidermolysis Bullosa DystrophicaEpidermolysis BullosaHumansAntibodies, Monoclonal, HumanizedCollagen Type VII

Substanzen

dupilumabAntibodies, Monoclonal, HumanizedCollagen Type VII

Autor:innen und Institutionen

  • Department of Dermatology, Guangzhou Institute of Dermatology, Guangzhou, China.
  • Institute of Dermatology, Guangzhou Medical University, Guangzhou, China.

Förderung

  • Science and Technology General guidance project of Guangzhou Health

Zitieren

APA

Shao, L., Zhong, D. Q., Liu, Y. M., & Wang, J. Q. (2023). Dupilumab as a novel therapy for epidermolysis bullosa pruriginosa. International Journal of Dermatology. https://doi.org/10.1111/ijd.16752

Vancouver

Shao L, Zhong DQ, Liu YM, Wang JQ. Dupilumab as a novel therapy for epidermolysis bullosa pruriginosa. International Journal of Dermatology. 2023. doi:10.1111/ijd.16752

BibTeX
@article{Shao2023,
  author = {Shao, Lei and Zhong, Dao-Qing and Liu, Yu-Mei and Wang, Jian-Qin},
  title = {Dupilumab as a novel therapy for epidermolysis bullosa pruriginosa},
  journal = {International Journal of Dermatology},
  year = {2023},
  doi = {10.1111/ijd.16752}
}
Kostenlos starten →